US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Wawona Frozen Foods Voluntarily Recalls Organic Daybreak Blend Processed and Sold in 2022 Due to Possible Health Risk

      Summary Company Announcement Date: June 08, 2023 FDA Publish Date: June 09, 2023 … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Hospira Announces A Nationwide Recall Of Three Lots Of Propofol Due To Glass Vial Defect

Hospira Announces A Nationwide Recall Of Three Lots Of Propofol Due To Glass Vial Defect

August 30, 2012 By The FDA Leave a Comment

Hospira, Inc. (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, today announced a nationwide recall of three lots of Propofol Injectable Emulsion, 1%, 1g/100 mL, due to visible particles embedded in the glass to the user level. There may be potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution. In the event in which particulate matter could be injected into a patient, there may be the potential for patient injury where medical intervention may be required. Risks associated with this defect could include tissue necrosis in one or more organs that could result in stroke, myocardial infarction, respiratory failure, and loss of renal and hepatic function.

Hospira has not received any reports of adverse events related to these lots. Hospira has initiated an investigation to determine root cause and corrective and preventive measures. The investigation has preliminarily identified the root cause as a supplier glass defect. Hospira is working with its glass vial supplier to determine the cause of the defect.

The product is packaged in vials and indicated for the induction or maintenance of anesthesia in surgical patients or to initiate sleep in intensive care units. The affected lots were distributed nationwide to wholesalers and direct customers from September 2011 through February 2012. Hospira has issued a recall letter to U.S. customers voluntarily recalling the following lots:

Product

NDC Number

Lot*

Expiration Date

Propofol Injectable Emulsion, 1%,
1 g / 100 mL (10 mg/mL)

0409-4699-24

07-893-DJ

01JUL2013

10-123-DJ

01OCT2013

10-125-DJ

01OCT2013

This recall is being conducted as a precautionary measure. The company is notifying its distributors and customers by letters and is arranging for return/replacement etc. of all recalled products. Anyone with an existing inventory in the United States should stop use and distribution, quarantine the product immediately and call Stericycle at 1-888-410-7509, between the hours of 8 a.m. to 5 p.m. EDT, Monday through Friday, to arrange for the return of the product. Customers can call Hospira Customer Care at 1-877-976-7747, between the hours of 8 a.m. to 5 p.m. CDT, Monday through Friday, to inquire about product availability.

For medical inquiries, please contact Hospira Medical Communications at 1-800-615-0187. This phone number is available 24 hours a day, seven days a week. Any adverse reactions or quality problems experienced with the use of these products may be reported to the FDA’s MedWatch Adverse Events Program either online, by regular mail or by fax.

  • Online: www.fda.gov/medwatch/report.htm
  • Regular mail: use postage-paid, pre-addressed Form FDA3500 available at www.fda.gov/MedWatch/getforms.htm
  • Fax: 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

About Hospira
Hospira, Inc. is the world’s leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com disclaimer icon .

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Wawona Frozen Foods Voluntarily Recalls Organic Daybreak Blend Processed and Sold in 2022 Due to Possible Health Risk

June 7, 2023 By The FDA

Wawona Frozen Foods Inc. Recalls Organic Daybreak Blend Because of Potential Hepatitis A Contamination

June 7, 2023 By The FDA

TJX Recalls Haining Degao Benches Due to Fall Hazard

June 7, 2023 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Bell Sports Recalls Giro Merit Helmets Due to Risk of Head Injury

June 7, 2023 By The CPSC

TopGlore Recalls Narskido Infant Bath Seats Due to Drowning Hazard; Sold Exclusively on Amazon.com (Recall Alert)

June 7, 2023 By The CPSC

Children’s Pajamas Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by Deux Par Deux (Recall Alert)

June 7, 2023 By The CPSC

Textron Specialized Vehicles Recalls Arctic Cat 8000 Snowmobiles Due to Fire Hazard (Recall Alert)

June 7, 2023 By The CPSC

John Deere Recalls XUV590 Gator Utility Vehicles Due to Fire Hazard (Recall Alert)

June 7, 2023 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Textron Specialized Vehicles Recalls Arctic Cat 8000 Snowmobiles Due to Fire Hazard (Recall Alert)

June 7, 2023 By The CPSC

John Deere Recalls XUV590 Gator Utility Vehicles Due to Fire Hazard (Recall Alert)

June 7, 2023 By The CPSC

Children’s Pajamas and Nightdresses Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by Little Cotton Clothes (Recall Alert)

June 7, 2023 By The CPSC

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Wawona Frozen Foods Voluntarily Recalls Organic Daybreak Blend Processed and Sold in 2022 Due to Possible Health Risk
  • Wawona Frozen Foods Inc. Recalls Organic Daybreak Blend Because of Potential Hepatitis A Contamination
  • TJX Recalls Haining Degao Benches Due to Fall Hazard
  • Allied Air Enterprises Recalls Armstrong Air and Air Ease Gas Furnaces Due to Carbon Monoxide Poisoning Hazard
  • Ashley Furniture Industries Recalls Party Time Power Loveseats, Sofas and Recliners Due to Fire Hazard
  • Bell Sports Recalls Giro Merit Helmets Due to Risk of Head Injury
  • TopGlore Recalls Narskido Infant Bath Seats Due to Drowning Hazard; Sold Exclusively on Amazon.com (Recall Alert)
  • Children’s Pajamas Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by Deux Par Deux (Recall Alert)
  • Textron Specialized Vehicles Recalls Arctic Cat 8000 Snowmobiles Due to Fire Hazard (Recall Alert)
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in